This statistic shows the projection of the distribution of cost-sharing for generic drugs in the Medicare Part D coverage gap in the United States from 2016 to 2020. In 2016, 42 percent of the cost of generic drugs is expected to be paid by CMS. Provisions of the Affordable Care Act mandate the gradual closure of the Medicare Part D coverage gap through pharmaceutical manufacturer discounts and CMS subsidies.
Cost sharing for generic drug costs in the Medicare Part D coverage gap from 2016 to 2020
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Medicare Part D payer share of branded and generic drugs by therapy area 2015
- Payer share of Medicare Part D retail prescriptions by therapy class 2018
- Medicare hospital inpatient charges by disease in the U.S. 2017
- Share of branded drug costs in Medicare Part D gap in the U.S. 2016-2020
- Medicare inpatient hospital ALOS in U.S. cases by disease and IDN status 2016
- Medicare savings through generic drug usage in the U.S. by state 2015
- Medicare hospital inpatient case charges by severity in the U.S. 2014
- Managed Care percentage in the U.S. of total Medicare spending 2007-2019
- Total Medicare Advantage enrollment in the U.S. 2004-2021
- Number of Medicare Advantage plans 2010-2022, by plan type
- Medicare reimbursements of inpatient charges in the U.S. by condition 2019
- Leading U.S. not-for-profit hospitals by Medicare patient charges 2016
- Medicare - number of general hospital facilities in the U.S. 1967-2014
- Share of hospitals penalized by Medicare for high readmission rates U.S. 2013-2017
- Medicare hospital readmission rates U.S. 2005-2014, by initial diagnosis
- Medigap enrollment in top U.S states 2020
- Share of hospitals with Medicare penalty for high readmission rate by location 2017
Sanofi. (December 30, 2015). Cost sharing for generic drug costs in the Medicare Part D coverage gap from 2016 to 2020 [Graph]. In Statista. Retrieved August 18, 2022, from https://www.statista.com/statistics/320743/distribution-of-generic-drug-costs-in-medicare-part-d-coverage-gap-in-the-us/
Sanofi. "Cost sharing for generic drug costs in the Medicare Part D coverage gap from 2016 to 2020 ." Chart. December 30, 2015. Statista. Accessed August 18, 2022. https://www.statista.com/statistics/320743/distribution-of-generic-drug-costs-in-medicare-part-d-coverage-gap-in-the-us/
Sanofi. (2015). Cost sharing for generic drug costs in the Medicare Part D coverage gap from 2016 to 2020 . Statista. Statista Inc.. Accessed: August 18, 2022. https://www.statista.com/statistics/320743/distribution-of-generic-drug-costs-in-medicare-part-d-coverage-gap-in-the-us/
Sanofi. "Cost Sharing for Generic Drug Costs in The Medicare Part D Coverage Gap from 2016 to 2020 ." Statista, Statista Inc., 30 Dec 2015, https://www.statista.com/statistics/320743/distribution-of-generic-drug-costs-in-medicare-part-d-coverage-gap-in-the-us/
Sanofi, Cost sharing for generic drug costs in the Medicare Part D coverage gap from 2016 to 2020 Statista, https://www.statista.com/statistics/320743/distribution-of-generic-drug-costs-in-medicare-part-d-coverage-gap-in-the-us/ (last visited August 18, 2022)